Clinical Trial Update: Ga68-DOTA-NOC-PET Imaging of Neuroendocrine Tumors

View source ↗

Summary

This entry provides an update on a clinical trial evaluating Ga-68-DOTA-NOC PET imaging for patients with neuroendocrine tumors.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Neuroendocrine Tumor

Drugs mentioned

• Ga-68-DOTA-NOC (Ga-68 labeled DOTA-NOC radiotracer)

Snippet

Sponsor: Hadassah Medical Organization | Conditions: Neuroendocrine Tumor | Status: UNKNOWN